Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
Presentation Icons
Event Add-on
In Person Only
Off-site Event
Location: Marriott Marquis
Back
Main Session
Favorite
Facebook
Tweet
EDU 12 - Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
Radiotherapy Renaissance - Whats New in Stage III NSCLC?
Sunday, September 29, 2024
5:32 PM – 5:47 PM
ET
Location: Room 146
Speaker(s)
Alexander Louie, MD, PhD, MSc, FRCPC
Sunnybrook Health Sciences Centre
Toronto, ON, Canada
Learning Objectives:
Recognize the relevant roles of biomarker testing, novel therapeutics and precision surgery/radiotherapy in the management of stage III NSCLC.
Recognize the difference in the meaning of resectability and operability, as it relates to stage III NSCLC.
Review the continued role of radiotherapy in the curative management of stage III NSCLC, including neoadjuvant/adjuvant and definitive strategies.